Home LiteratureArticle Details
PMID: 6409929 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects.

The Journal of clinical investigation ·Vol. 72 ·No. 1 ·1983-07-00 ·Pages 270-7

Tse TF, Clutter WE, Shah SD, Miller JP, Cryer PE

Abstract

The mechanisms of postprandial glucose counterregulation-those that blunt late decrements in plasma glucose, prevent hypoglycemia, and restore euglycemia-have not been fully defined. To begin to clarify these mechanisms, we measured neuroendocrine and metabolic responses to the ingestion of glucose (75 g), xylose (62.5 g), mannitol (20 g), and water in ten normal human subjects to determine for each response the magnitude, temporal relationships, and specificity for glucose ingestion. Measurements were made at 10-min intervals over 5 h. By multivariate analysis of variance, the plasma glucose (P < 0.0001), insulin (P < 0.0001), glucagon (P < 0.03), epinephrine (P < 0.0004), and growth hormone (P < 0.01) curves, as well as the blood lactate (P < 0.0001), glycerol (P < 0.001), and beta-hydroxybutyrate (P < 0.0001) curves following glucose ingestion differed significantly from those following water ingestion. However, the growth hormone curves did not differ after correction for differences at base line. In contrast, the plasma norepinephrine (P < 0.31) and cortisol (P < 0.24) curves were similar after ingestion of all four test solutions, although early and sustained increments in norepinephrine occurred after all four test solutions. Thus, among the potentially important glucose regulatory factors, only transient increments in insulin, transient decrements in glucagon, and late increments in epinephrine are specific for glucose ingestion. They do not follow ingestion of water, xylose, or mannitol. Following glucose ingestion, plasma glucose rose to peak levels of 156+/-6 mg/dl at 46+/-4 min, returned to base line at 177+/-4 min, reached nadirs of 63+/-3 mg/dl at 232+/-12 min, and rose to levels comparable to base line at 305 min, which was the final sampling point. Plasma insulin rose to peak levels of 150+/-17 muU/ml (P < 0.001) at 67+/-8 min. At the time glucose returned to base line, insulin levels (49+/-12 muU/ml) remained fourfold higher than base line (P < 0.01); thereafter they declined but never fell below base line. Plasma glucagon decreased from 95+/-14 pg/ml to nadirs of 67+/-11 pg/ml (P < 0.001) at 84+/-9 min and then rose progressively to peak levels of 114+/-17 pg/ml (P < 0.001 vs. nadirs) at 265+/-12 min. Plasma epinephrine, which was 18+/-4 pg/ml at base line, did not change initially and then rose to peak levels of 119+/-20 pg/ml (P < 0.001) at 271+/-13 min. These data indicate that the glucose counterregulatory process late after glucose ingestion is not solely due to the dissipation of insulin and that sympathetic neural norepinephrine, growth hormone, and cortisol do not play critical roles. They are consistent with, but do not establish, physiologic roles for the counterregulatory hormones-glucagon, epinephrine, or both-in that process.

MeSH Terms
3-Hydroxybutyric Acid Adult Blood Glucose/metabolism Epinephrine/blood Female Glucagon/blood Glucose Glycerol/blood Growth Hormone/blood Humans Hydroxybutyrates/blood Insulin/blood Kinetics Lactates/blood Lactic Acid Male Mannitol Norepinephrine/blood Xylose
Chemicals
Blood Glucose Hydroxybutyrates Insulin Lactates Lactic Acid Mannitol Growth Hormone Glucagon Xylose Glucose Glycerol 3-Hydroxybutyric Acid Norepinephrine Epinephrine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Tse T F
Clutter W E
Shah S D
Miller J P
Cryer P E
References (46)
46 references, click to expand
  1. Hormone-fuel interrelationships during fasting.
    J Clin Invest. 1966 Nov;45(11):1751-69 PMID: 5926444
  2. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.
    J Clin Invest. 1967 Mar;46(3):323-35 PMID: 6023769
  3. Diminished insulin response to hyperglycemia in prediabetes and diabetes.
    Diabetes. 1967 Aug;16(8):560-5 PMID: 6041184
  4. Enzymic assay of glycerol, dihydroxyacetone, and glyceraldehyde.
    Arch Biochem Biophys. 1967 Aug;121(2):404-14 PMID: 6057108
  5. Insulin secretion in diabetes mellitus.
    Ann Intern Med. 1968 Nov;69(5):891-901 PMID: 5698485
  6. Is there a delay in the plasma insulin response of patients with chemical diabetes mellitus?
    Diabetes. 1971 Jun;20(6):416-23 PMID: 5556900
  7. Glucagon physiology and pathophysiology.
    N Engl J Med. 1971 Aug 19;285(8):443-9 PMID: 4997492
  8. Forearm glucose uptake during the oral glucose tolerance test in normal subjects.
    Diabetes. 1973 Jun;22(6):442-58 PMID: 4713669
  9. Plasma cortisol determination: radioimmunoassay and competitive protein binding compared.
    Clin Chem. 1974 Apr;20(4):411-4 PMID: 4856379
  10. A model of the kinetics of insulin in man.
    J Clin Invest. 1974 May;53(5):1481-92 PMID: 4856884
  11. Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture.
    J Clin Endocrinol Metab. 1974 Dec;39(6):1025-9 PMID: 4473459
  12. Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma.
    Am J Med. 1975 Feb;58(2):285-93 PMID: 46704
  13. The control of glycogen metabolism in the liver.
    Annu Rev Biochem. 1976;45:167-89 PMID: 183599
  14. Initial splanchnic extraction of ingested glucose in normal man.
    Metabolism. 1978 Jun;27(6):657-69 PMID: 651653
  15. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
    J Clin Invest. 1978 Aug;62(2):487-91 PMID: 670404
  16. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.
    J Clin Invest. 1979 Jan;63(1):114-23 PMID: 762240
  17. Adrenergic mechanisms in recovery from hypoglycemia in man: adrenergic blockade.
    Am J Physiol. 1979 Feb;236(2):E147-52 PMID: 420285
  18. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.
    J Clin Endocrinol Metab. 1979 Jan;48(1):171-5 PMID: 422700
  19. Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man.
    Am J Physiol. 1979 Apr;236(4):E380-5 PMID: 434200
  20. Blood glucose regulates the effects of insulin and counterregulatory hormones on glucose production in vivo.
    Diabetes. 1979 Jun;28(6):533-6 PMID: 446911
  21. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    J Clin Invest. 1979 May;63(5):849-57 PMID: 447832
  22. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    J Clin Invest. 1979 Jul;64(1):62-71 PMID: 36413
  23. Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration.
    Diabetes. 1980 Feb;29(2):125-31 PMID: 6986297
  24. Evidence for an important role of changes in rather than absolute concentrations of glucagon in the regulation of glucose production in humans.
    J Clin Endocrinol Metab. 1980 Apr;50(4):698-703 PMID: 6988453
  25. Enhanced plasma norepinephrine response to upright posture and oral glucose administration in elderly human subjects.
    Metabolism. 1980 Jun;29(6):532-9 PMID: 6991857
  26. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system.
    N Engl J Med. 1980 Aug 21;303(8):436-44 PMID: 6248784
  27. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.
    J Clin Invest. 1980 Jul;66(1):94-101 PMID: 6995479
  28. Increased plasma norepinephrine concentrations and metabolic rates following glucose ingestion in man.
    Metabolism. 1980 Sep;29(9):806-9 PMID: 6997675
  29. Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man.
    J Clin Endocrinol Metab. 1980 Oct;51(4):877-83 PMID: 6999000
  30. Influence of small increments of epinephrine on glucose tolerance in normal humans.
    Ann Intern Med. 1980 Oct;93(4):566-8 PMID: 7001974
  31. Counterregulatory hormones during moderate, insulin-induced, blood glucose decrements in man.
    J Clin Endocrinol Metab. 1981 Mar;52(3):477-82 PMID: 7007409
  32. Glucose counterregulation in man.
    Diabetes. 1981 Mar;30(3):261-4 PMID: 6110601
  33. Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans.
    J Clin Endocrinol Metab. 1981 Jun;52(6):1235-41 PMID: 7014600
  34. Epinephrine plasma thresholds for lipolytic effects in man: measurements of fatty acid transport with [l-13C]palmitic acid.
    J Clin Invest. 1981 Jun;67(6):1729-38 PMID: 7016921
  35. Dose-response characteristics for effects of insulin on production and utilization of glucose in man.
    Am J Physiol. 1981 Jun;240(6):E630-9 PMID: 7018254
  36. Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man.
    J Clin Endocrinol Metab. 1981 Sep;53(3):556-9 PMID: 6114964
  37. Thermic effect of feeding in man: increased plasma norepinephrine levels following glucose but not protein or fat consumption.
    Metabolism. 1981 Oct;30(10):953-8 PMID: 7024722
  38. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    J Clin Invest. 1982 Feb;69(2):315-26 PMID: 6120181
  39. Selective counterregulatory hormone responses after oral glucose in man.
    J Clin Endocrinol Metab. 1982 Oct;55(4):787-90 PMID: 7107822
  40. In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in man.
    Diabetes. 1982 Oct;31(10):929-36 PMID: 6759226
  41. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones.
    J Clin Endocrinol Metab. 1978 Nov;47(5):1160-3 PMID: 400737
  42. Juvenile diabetes mellitus, a deficiency in insulin.
    Diabetes. 1968 Jan;17(1):27-32 PMID: 4952859
  43. Immunoassay of insulin with insulin-antibody precipitate.
    Biochem J. 1963 Jul;88:137-46 PMID: 13952078
  44. Secretion of human growth hormone: physiologic and experimental modification.
    Metabolism. 1963 Jul;12:577-9 PMID: 13975314
  45. EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.
    J Biol Chem. 1964 Jan;239:18-30 PMID: 14114842
  46. A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA.
    Nature. 1964 Sep 12;203:1141-2 PMID: 14213659
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1983-07-00
Pages
270-7
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC1129182
Subset
IM
Grants
NIADDK NIH HHS · AM 20579 · United States
NIADDK NIH HHS · AM 27085 · United States
NCRR NIH HHS · RR 00036 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]